A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its inner core into the host cell's nuclear membrane. The findings ...

To become infectious, HIV has to undergo a maturation process, which involves a rearrangement of the matrix proteins (red). In an immature virus particle, the matrix proteins form a lose lattice ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

Mice whose brains express the HIV-1 Tat protein show a heightened response to the drug and appear more vulnerable to relapse. Kerry served as The Scientist’s news director until 2021. Before joining ...

Four crew members will embark on a new long-duration science expedition when they launch to the International Space Station ...

A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten to undermine progress.

In a ceremony held last month, the 2024 Louisa Gross Horwitz Prize was awarded to Wesley Sundquist, PhD, Leo T. and Barbara K ...

CD8 + T cells can recognize and then kill HIV-infected cells following the presentation of fragments of viral proteins (epitopes) in the peptide-binding groove of MHC class I molecules on the ...